AFG
IHE icon

Arkansas Financial Group’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Arkansas Financial Group’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.33M Buy
23,489
+14,478
+161% +$1.3M 0.3% 45
2026
Q1 		$791K Buy
9,011
+1,876
+26% +$164K 0.11% 60
2025
Q4 		$605K Sell
7,135
-280
-4% -$22.3K 0.09% 63
2025
Q3 		$538K Buy
7,415
+702
+10% +$48.4K 0.08% 64
2025
Q2 		$440K Hold
6,713
– – 0.07% 64
2025
Q1 		$409K Sell
6,713
-210
-3% -$14.6K 0.07% 64
2024
Q4 		$455K Sell
6,923
-1,746
-20% -$120K 0.07% 63
2024
Q3 		$612K Buy
8,669
+3,454
+66% +$241K 0.1% 56
2024
Q2 		$346K Buy
+5,215
New +$342K 0.06% 61
2022
Q1 		– Sell
-3,081
Closed -$205K – 48
2021
Q4 		$205K Buy
+3,081
New +$195K 0.04% 47
2021
Q3 		– Sell
-3,270
Closed -$202K – 44
2021
Q2 		$202K Buy
+3,270
New +$199K 0.05% 45
2018
Q4 		– Sell
-3,588
Closed -$200K – 27
2018
Q3 		$200K Buy
+3,588
New +$196K 0.08% 24
2017
Q4 		– Sell
-3,882
Closed -$202K – 24
2017
Q3 		$202K Hold
3,882
– – 0.09% 22
2017
Q2 		$201K Buy
+3,882
New +$196K 0.09% 21
2016
Q1 		– Sell
-3,882
Closed -$209K – 22
2015
Q4 		$209K Buy
+3,882
New +$204K 0.13% 20
2015
Q3 		– Sell
-3,882
Closed -$226K – 21
2015
Q2 		$226K Sell
3,882
-390
-9% -$22.8K 0.14% 19
2015
Q1 		$246K Buy
4,272
+390
+10% +$21.3K 0.15% 20
2014
Q4 		$196K Sell
3,882
-1,215
-24% -$59.2K 0.12% 19
2014
Q3 		$238K Hold
5,097
– – 0.16% 19
2014
Q2 		$230K Sell
5,097
-402
-7% -$17.3K 0.16% 19
2014
Q1 		$232K Sell
5,499
-1,404
-20% -$58.9K 0.17% 19
2013
Q4 		$272K Buy
+6,903
New +$259K 0.21% 16

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Arkansas Financial Group's IHE Position: Q2 2026 in Review

Arkansas Financial Group increased its iShares US Pharmaceuticals ETF (IHE) stake by 161% in Q2 2026, buying an estimated $1.3M and bringing the position to 23,489 shares worth $2.33M. The position accounts for 0.3% of the portfolio, ranked #45.

Arkansas Financial Group first reported a position in IHE in Q4 2013 and has held it in 22 quarters since. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • Arkansas Financial Group held 23,489 shares of iShares US Pharmaceuticals ETF worth $2.33M as of Q2 2026.
  • Arkansas Financial Group bought 14,478 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $1.3M.
  • iShares US Pharmaceuticals ETF made up 0.3% of Arkansas Financial Group's portfolio in Q2 2026, its #45 holding.
  • Arkansas Financial Group first reported a position in iShares US Pharmaceuticals ETF in Q4 2013 and has held it in 22 quarters since.
  • 209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Arkansas Financial Group's 13F filing for Q2 2026, filed 20 Jul 2026.